This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.
1 Primary · 7 Secondary · Reporting Duration: Up to 5 years
Active Control
Experimental Treatment
624 Total Participants · 4 Treatment Groups
Primary Treatment: intensity-modulated radiation therapy · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: